Reversal of warfarin-induced coagulopathy: Review of treatment options

Journal of Emergency Nursing

Volumn 38, Issue 1, 2012, Pages 98-101

  Hall, A Brad ^a,b   Carson, Brittany C ^c  

^a LAKELAND REGIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c Carson is Director of Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN COMPLEX CONCENTRATES; VITAMIN K GROUP; WARFARIN;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; CHEMICALLY INDUCED DISORDER; FEMALE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MONITORING; PLASMA; RISK ASSESSMENT; TREATMENT OUTCOME;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; FACTOR VIIA; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; PLASMA; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN K; WARFARIN;

EID: 84855329329     PISSN: 00991767     EISSN: 15272966     Source Type: Journal    
DOI: 10.1016/j.jen.2010.12.015     Document Type: Article

References (8)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133(6 Suppl):160S-198S.
2. Duguid J, O'Shaughnessy D, Atterbury C, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004, 126:11-28.
3. NovoSeven [package insert]. Princeton, NJ: Novo Nordisk; 2010.
4. Dager WE, King JH, Regalia RC, et al. Reversal of elevate international normalized ratios and bleeding with low-dose recombinant activated factor VIIa in patients receiving warfarin. Pharmacotherapy 2006, 26(8):1091-1098.
5. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 2005, 57:832-836.
6. Deveras R, Kessler C Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002, 137:884-888.
7. Sorensen B, Johansen P, Nielsen G, Sorensen J, Ingerslev J Reversal of the international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003, 14:469-477.
8. Holland L, Warkentin T, Refaai M, Crowther M, Johnston M, Sarode R Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009, 49:1171-1177.